Science & Technology
Therapeutic Agents Targeting Cryptococcal Infections
Department of Health and Human Services — National Institutes of Health
Opportunity #: 1R41AI172564-01A1
Award Ceiling
$598K
Award Floor
$598K
Close Date
Feb 28, 2025
Total Funding
$598K
Expected Awards
1
Posted Date
Mar 8, 2023
Cost Sharing Required
No
Grants.gov ID
sbir-1R41AI172564-01A1
Description
STTR Phase Phase I award: "Therapeutic Agents Targeting Cryptococcal Infections" awarded to Quercus Molecular Design, LLC in Wilmington, Delaware. Funded by Department of Health and Human Services (National Institutes of Health). Award amount: $597,725. The SBIR/STTR programs fund innovative research and development by small businesses, with Phase I for feasibility studies and Phase II for full R&D.
Eligible Applicants
Small businesses
Apply on Grants.gov
Always verify details and apply through the official Grants.gov portal. Information here may not reflect the latest changes.
View on Grants.govDisclaimer: This information is sourced from Grants.gov and may not reflect the most current details. Always verify eligibility requirements, deadlines, and application procedures on the official program website before applying.